Loading summary
A
Waymo is making a multi billion dollar bet that its self driving cars are the future of driving. Will it pay off? Find out in Waymo and the Robo Taxi Race, a new series in the WSJ's Future of Everything feed.
B
Hey listeners, it's Saturday, January 11th. I'm Francesca Fontana for the Wall Street Journal and this is what's News in Markets, our look at the biggest stock moves of the week and the news that drove them. Let's get we had another short trading week this week with markets closed Thursday for our national day of mourning in honor of former President Jimmy Carter. But during the four trading sessions we did have, there was plenty of action. Primarily, we saw the markets react to the devastating wildfires that broke out on Tuesday in Los Angeles and have wreaked havoc across the region. In the case of this kind of natural disaster, we can see investors concerns affecting stocks like the local utilities such as Southern California Electric Co. Edison International. And there are the home and auto insurance stocks like Allstate, AIG and others. And their shares fell on Friday as analysts estimate that the devastation will cost insurers billions of dollars. On Friday, we also got the December jobs report, which topped expectations. Way more jobs were created than anticipated, which suggests that the labor market has recovered and it might even be gaining steam. As we've discussed before on this podcast, the jobs report is an important consideration for the Federal Reserve and for traders guesses as to where interest rates are headed. So now investors are pricing in just one rate cut this year. All three major indexes, the Dow, the S&P 500 and the Nasdaq, ended the week lower. The Dow and the S and P each fell about 1.9% and the Nasdaq lost more than 2%. Now first up, let's talk Fubo. That's F U B O Fubo TV, the sports streamer that announced a big deal with Disney at the start of the week. So Disney agreed to combine its Hula plus live TV streaming service with fubo. It's a deal that will also end pending litigation between them. Now, full disclosure, I am not a big sports guy myself, though I do tune into some hockey now and again. But I have been keeping up on the Fubo Disney drama because there has been drama beef, even quick play by play. Last year, Disney, espn, Warner Bros. Discovery and Fox Corp. Say they're creating a joint streaming service, a supergroup of live sports named Venu Venu Venue. No, it's pronounced Venue. Then Fubo sued all three companies to try and block the venture it alleges that Disney at all wouldn't let Fubo carry a small bundle of sports focused channels that the big three partners wanted to include in venue. The judge comes in with a preliminary injunction blocking the watch. And now Disney and Fubo are mending fences, joining forces. And on Friday, Disney, Fox and Warner Bros. Called off their big venture. No more venue. Quick side note, Fox and Wall Street Journal parent News Corp. Share common ownership. So how big a win was this week for Fubo's stock? Well, it was huge. On Monday, FuboTV shares surged 251%. The stock then added a relatively modest 7.9% to that on Tuesday and made some smaller moves lower Wednesday and Friday. Next up, let's talk about vaccines. No, not for Covid like we're all used to hearing about. No, this time for the H5N1 bird flu. And we're going to talk about the biotech firms that are making these shots, like Moderna and novavax. Specifically, they're developing experimental vaccines against pandemic influenza, including this avian strain that has infected more than 60 people in the US in the past year. So on Monday, US health officials confirmed the first American death caused by this flu, which put these stocks into focus because this death could spur more federal funding for the vaccine's development. Moderna's efforts are part of a $176 million federal contract that it received last year. It could also prompt purchase orders of the shots, that is, if the vaccines succeed in testing and are authorized by regulators. As a result, Moderna shares jumped more than 11.5% on Tuesday and Novavax gained 10.9%. And now you know what's news in markets this week. You can read about more stocks that moved on the week's news in the Score, my column in the Wall Street Journal's Exchange section. Today's show is produced by Pierre Bienname with supervising producer Talia Bell. I'm Francesca Fontana. Have a great weekend and see you next Saturday.
WSJ What’s News in Markets: FuboTV Scores, Vaccine Bets, Insurers Stumble Released on January 11, 2025
Host: Francesca Fontana, The Wall Street Journal
Short Trading Week Amid National Mourning
The trading week was notably shortened as markets observed a national day of mourning in honor of former President Jimmy Carter, resulting in the closure of markets on Thursday. Despite the shortened session, significant movements occurred over the four trading days.
Impact of Los Angeles Wildfires
A major catalyst for market activity was the devastating wildfires that erupted in Los Angeles on Tuesday, causing widespread destruction across the region. Francesca Fontana highlights the investor concerns stemming from such natural disasters:
"[Investors are] concerned about how these wildfires will impact local utilities and insurance companies" ([01:00]).
Stocks in the utilities sector, including Southern California Electric Co. and Edison International, experienced declines. Similarly, insurance giants like Allstate and AIG saw their shares drop as analysts projected billions in potential losses for insurers due to the wildfires.
December Jobs Report Exceeds Expectations
On Friday, the release of the December jobs report surprised economists by surpassing expectations, indicating robust job creation. This strong performance suggests that the labor market is not only recovering but may also be gaining momentum. The implications for the Federal Reserve are significant, as a healthier job market could influence interest rate decisions.
"The jobs report is an important consideration for the Federal Reserve and for traders' guesses as to where interest rates are headed" ([03:20]).
As a result of the positive jobs data, investors began pricing in only one rate cut for the year. Consequently, all three major indices closed the week lower:
Major Deal and Litigation Settlement
FuboTV, the sports streaming service, made headlines with a significant partnership announcement with Disney earlier in the week. Disney has agreed to merge its Hulu + Live TV streaming service with FuboTV, effectively ending ongoing litigation between the two entities.
"Disney agreed to combine its Hulu + Live TV streaming service with Fubo, a deal that will also end pending litigation" ([05:00]).
Background of the Dispute and "Venue" Venture
The partnership comes after a turbulent relationship between Disney and FuboTV. Last year, Disney, alongside ESPN, Warner Bros. Discovery, and Fox Corp., planned to launch a joint streaming service named "Venue," aimed at consolidating live sports content. FuboTV contested this move, alleging that Disney would restrict their access to a select bundle of sports-focused channels that the consortium intended to include in Venue. This legal battle culminated in a preliminary injunction that blocked the Venue venture.
"Fubo sued all three companies to try and block the venture, alleging that Disney wouldn't let Fubo carry a small bundle of sports-focused channels" ([06:10]).
With Disney, Fox, and Warner Bros. now calling off the Venue project, FuboTV's stock experienced a dramatic surge.
Stock Performance
FuboTV’s stock saw substantial gains following the announcement:
This resurgence underscores the market's positive reception to the resolution of the Disney-Fubo dispute and the strategic partnership formed.
Emergence of H5N1 and Vaccine Development Efforts
Shifting focus to the healthcare sector, the podcast discusses the development of vaccines for the H5N1 bird flu, a concerning strain that has infected over 60 people in the United States within the past year. This emerging health threat has reignited efforts to develop effective vaccines beyond the more familiar COVID-19.
Biotech Firms Moderna and Novavax
Biotech companies Moderna and Novavax are at the forefront of this initiative, working on experimental vaccines targeting pandemic influenza strains, including H5N1. The urgency was heightened when U.S. health officials confirmed the first American death from the bird flu on Monday.
"The first American death caused by this flu puts these stocks into focus because this could spur more federal funding" ([08:30]).
Federal Funding and Market Impact
Moderna has secured a $176 million federal contract to support its vaccine development efforts. The progress of these vaccines could lead to substantial purchase orders, contingent on successful testing and regulatory approval.
As a result of these developments, Moderna and Novavax saw significant stock movements:
These gains reflect investor optimism regarding the potential for federal support and the commercial viability of successful H5N1 vaccines.
Francesca Fontana encapsulates the week’s market dynamics, emphasizing the interplay between natural disasters, economic indicators, corporate partnerships, and advancements in healthcare. Key takeaways include:
For a more comprehensive analysis of stock movements driven by the week's news, readers are encouraged to explore Francesca Fontana's column in the Wall Street Journal's Exchange section.
"Today’s show is produced by Pierre Bienname with supervising producer Talia Bell. I'm Francesca Fontana. Have a great weekend and see you next Saturday." ([09:50]).
Produced by: Pierre Bienname
Supervising Producer: Talia Bell
Host: Francesca Fontana